Can supplementation of vitamins and minerals boost the effectiveness of recombinant human erythropoietin therapy?

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Nephrology

• Publication date

  2002-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1046/j.1440-1797.7.s.2.x
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Intravenous ascorbic acid as an adjuvant therapy for recombinant erythropoietin in hemodialysis patients with hyperferritinemia.

  1999cited by this paper
• Zinc status relates to hematological deficits in middle-aged women.

  1998cited by this paper
• High-dose alfacalcidol improves anaemia in patients on haemodialysis.

  1997cited by this paper
• A cost-effectiveness analysis of anemia screening before erythropoietin in patients with end-stage renal disease.

  1997cited by this paper
• Erythropoietin and oxidative stress in haemodialysis: beneficial effects of vitamin E supplementation.

  1997cited by this paper
• Low serum vitamin B12 levels in chronic high-flux haemodialysis patients.

  1997cited by this paper
• Metabolism of vitamin B6 and its requirement in chronic renal failure.

  1997cited by this paper
• Vitamin B6 and hemodialysis: the impact of high-flux/high-efficiency dialysis and review of the literature.

  1996cited by this paper
• Reduced glutathione for the treatment of anemia during hemodialysis: a preliminary communication.

  1995cited by this paper
• Evaluation of red blood cell lipoperoxidation in hemodialysed patients during erythropoietin therapy supplemented or not with iron.

  1995cited by this paper
• Resistance to erythropoietin in iron-overloaded haemodialysis patients can be overcome by ascorbic acid administration.

  1995cited by this paper
• Folic acid supplementation improves erythropoietin response.

  1995cited by this paper
• Zinc‐induced sideroblastic anemia: Report of a case, review of the literature, and description of the hematologic syndrome

  1994cited by this paper
• Medical treatment of severe hyperparathyroidism and its influence on anaemia in end-stage renal failure.

  1994cited by this paper
• Effect of serum parathyroid hormone and bone marrow fibrosis on the response to erythropoietin in uremia.

  1993cited by this paper
• Erythrocyte vitamins B1, B2 and B6 and erythropoietin.

  1993cited by this paper
• Water soluble vitamins in chronic hemodialysis patients and need for supplementation.

  1993cited by this paper
• Erythropoietin Resistance due to Vitamin B12 Deficiency

  1992cited by this paper
• Erythropoietin resistance due to vitamin B12 deficiency. Case report and retrospective analysis of B12 levels after erythropoietin treatment.

  1992cited by this paper
• Is folate supplementation necessary in hemodialysis patients on erythropoietin therapy.

  1992cited by this paper
• The effect of vitamin C intake on plasma oxalate in patients on regular haemodialysis.

  1991cited by this paper
• Discovery of human zinc deficiency and studies in an experimental human model.

  1991cited by this paper
• Serum erythropoietin and erythropoiesis in primary and secondary hyperparathyroidism: effect of parathyroidectomy.

  1991cited by this paper
• Ca++ and 1,25(OH)2D3 regulate in vitro and in vivo the response to human recombinant erythropoietin in CAPD patients.

  1990cited by this paper
• Zinc toxicity.

  1990cited by this paper
• Zinc in kidney disease.

  1989cited by this paper
• Evidence that serum calcium oxalate supersaturation is a consequence of oxalate retention in patients with chronic renal failure.

  1986cited by this paper
• Trace metals and anemia in chronic hemodialysis patients.

  1986cited by this paper
• Longitudinal follow-up of chronic hemodialysis patients without vitamin supplementation.

  1986cited by this paper
• Rapid progression of oxalosis-induced cardiomyopathy despite adequate haemodialysis.

  1984cited by this paper
• Water soluble vitamins in granulocytes, erythrocytes, and plasma obtained from chronic hemodialysis patients.

  1984cited by this paper
• Lack of effect of vitamin E therapy on the anemia of patients receiving hemodialysis.

  1984cited by this paper
• The role of ascorbic acid in the turnover of storage iron.

  1983cited by this paper
• The role of ascorbic acid in the turnover of storage iron.

  1983cited by this paper
• Tissue ferritin in scorbutic guinea‐pigs

  1983cited by this paper
• Do patients receiving regular haemodialysis need folic acid supplements?

  1982cited by this paper
• Daily requirement for pyridoxine supplements in chronic renal failure.

  1981cited by this paper
• Anemia and secondary hyperparathyroidism.

  1978cited by this paper
• Vitamin B6 deficiency in uremia and its implications for the depression of immune responses.

  1974cited by this paper
• Decreased aspartate aminotransferase ("SGOT") activity in serum of uremic patients.

  1974cited by this paper
• Cardiac lesions in secondary oxalosis.

  1974cited by this paper
• Tocopherol deficiency in man.

  1967cited by this paper
• Siderosis in the Bantu. A combined histopathological and chemical study.

  1960cited by this paper
• The Enzymic Formation of Haem by the Incorporation of Iron into Protoporphyrin; Importance of. Ascorbic Acid, Ergothioneine and Glutathione

  1959cited by this paper

• No citing papers are available for this paper.